2022
DOI: 10.1080/1028415x.2021.2017662
|View full text |Cite
|
Sign up to set email alerts
|

Nutrigenomics in Parkinson’s disease: diversity of modulatory actions of polyphenols on epigenetic effects induced by toxins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 113 publications
0
2
0
Order By: Relevance
“…Nutrigenomics refers to the study of the impact of specific nutrients, dietary components or entire diet on gene expression and gene regulation (Patil et al, 2022). Although many perspectives of molecular basis of chronic diseases such as metabolomics, nutrigenomics, transcriptomics are emerging and being pursued, nutrigenomics is currently the most important and widely applied (Rodrigues-Costa et al, 2021;Patil et al, 2022).…”
Section: Nutrigenomics: the Promise And Application In Environmental ...mentioning
confidence: 99%
“…Nutrigenomics refers to the study of the impact of specific nutrients, dietary components or entire diet on gene expression and gene regulation (Patil et al, 2022). Although many perspectives of molecular basis of chronic diseases such as metabolomics, nutrigenomics, transcriptomics are emerging and being pursued, nutrigenomics is currently the most important and widely applied (Rodrigues-Costa et al, 2021;Patil et al, 2022).…”
Section: Nutrigenomics: the Promise And Application In Environmental ...mentioning
confidence: 99%
“…Curcumin and apigenin, two naturally occurring polyphenols, have recently been linked to the histone modification process. Curcumin has been shown to promote HDAC-mediated acetylation-deacetylation balance while apigenin trigger histone H3 on lysine 9 (H3K9) and histone H4 on lysine 12 (H4K12) acetylation ( Rodrigues-Costa et al, 2021 ). Curcumin therapy decreased apoptosis and improved motor impairments in a PARK7-knockout rat model of Parkinson's disease by targeting HDACs ( Chiu et al, 2013 ).…”
Section: Nutriepigenomics and Parkinson’s Diseasementioning
confidence: 99%